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Streptococcus agalactiae is an emerging pathogen of non-
pregnant human adults worldwide and a reemerging patho-
gen of dairy cattle in parts of Europe. To learn more about 
interspecies transmission of this bacterium, we compared 
contemporaneously collected isolates from humans and 
cattle in Finland and Sweden. Multilocus sequence typ-
ing identified 5 sequence types (STs) (ST1, 8, 12, 23, and 
196) shared across the 2 host species, suggesting possible 
interspecies transmission. More than 54% of the isolates 
belonged to those STs. Molecular serotyping and pilus is-
land typing of those isolates did not differentiate between 
populations isolated from different host species. Isolates 
from humans and cattle differed in lactose fermentation, 
which is encoded on the accessory genome and represents 
an adaptation to the bovine mammary gland. Serotype IV-
ST196 isolates were obtained from multiple dairy herds in 
both countries. Cattle may constitute a previously unknown 
reservoir of this strain.
Streptococcus agalactiae (group B Streptococcus) is a major cause of neonatal infectious disease in humans in 
many countries and is carried asymptomatically by a large 
proportion of adults. It is also recognized as an emerging 
pathogen in human adults worldwide and as a reemerging 
mammary pathogen of cattle in northern Europe (1–3). In 
adults, S. agalactiae is primarily associated with bactere-
mia, skin and soft tissue infections (SSTI), and urinary tract 
infections (UTI) and occasionally with necrotizing fasci-
itis, arthritis, toxic shock syndrome, endocarditis, or men-
ingitis (4–6). Host and pathogen factors contribute to the 
emergence of S. agalactiae among adults (3). Among hosts, 
at greater risk are elderly patients and persons with chronic 
underlying conditions such as alcohol abuse, diabetes mel-
litus, or immunosuppression (2,4,6). Within the pathogen, 
new strains such as serotype IV may contribute to disease 
emergence (7,8). Considering the risk factors for S. aga-
lactiae in nonpregnant adults and demographic changes in 
many countries, the incidence of group B streptococcal dis-
ease can be anticipated to increase (4).
In the 1950s, S. agalactiae was the most common mas-
titis-causing bacterium among dairy cattle in Europe, se-
verely reducing milk quality and quantity. In the 1960s, de-
velopment of disease control programs and introduction of 
legislation resulted in near eradication of S. agalactiae from 
several northern European countries, a situation that contin-
ued until the end of the 20th century (9). In the 21st century, 
farm management in northern Europe changed (e.g., fewer 
herds, increased average herd size, and introduction of au-
tomated milking systems). Concomitantly, the prevalence 
of S. agalactiae in bovine milk increased. In Denmark, 
in the first years of the 21st century, the proportion of S. 
agalactiae–positive herds tripled (1,9). Similar phenomena 
have been described for Sweden and Norway (1).
The presence of S. agalactiae in humans and cattle 
raises the question of whether interspecies transmission oc-
curs. This question is particularly pertinent in light of the 
emergence of S. agalactiae disease in adult humans and its 
reemergence in cattle. Several comparisons of S. agalacti-
ae in humans and cattle have been published, and most au-
thors conclude that isolates from these species form largely 
distinct populations with regard to the core genome and the 
accessory genome (10–12). Ideally, assessment of the po-
tential for interspecies transmission is based on the analysis 
of contemporaneous, sympatric isolates. With 1 exception 
(13), however, most comparative studies were not based 
on isolates from the same geographic region and the same 
period, or, if they were, they covered a very limited number 
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of S. agalactiae–positive farms or animals (14,15). Our aim 
with this study was to provide insight into the hazard of in-
terspecies transmission of S. agalactiae by comparing con-
temporaneous populations of S. agalactiae from humans 
and dairy cattle in Finland and Sweden. 
Materials and Methods
Isolates
A total of 81 isolates were collected at the Seinäjoki Central 
Hospital in the rural South Ostrobothnia district of Finland 
(2011, 2012) and from epidemiologically unrelated persons 
by the Department of Clinical Microbiology, University 
Hospital, Uppsala, in an urban area of Sweden (2012, 2013). 
Isolates originated from 12 patients with invasive disease 
(sepsis or meningitis), 37 with UTI, and 15 with SSTI and 
from 17 healthy carriers who were screened during preg-
nancy by use of vaginal swab or cervical fluid samples. Iso-
lates represented a convenience sample that covered both 
sexes and all age classes (online Technical Appendix Fig-
ure 1, http://wwwnc.cdc.gov/EID/article/22/12/15-1447-
Techapp1.pdf). Data were not collected with regard to farm 
or animal contact or dietary exposure.
During 2010–2012, a total of 108 isolates from cattle 
were collected by the laboratory of Valio Ltd, Helsinki, 
Finland (63 isolates from 29 herds) and by the National 
Veterinary Institute, Uppsala, Sweden (45 isolates from 
45 herds). Isolates were cultured from individual cow or 
quarter milk samples from animals with suspected intra-
mammary infection with or without clinical signs. In both 
countries, samples originated from most of the major dairy 
regions (online Technical Appendix Figure 2). For 9 herds 
in Finland, isolates from multiple cows were available and 
2–14 isolates/herd were used to assess within-herd strain 
heterogeneity (online Technical Appendix Table 1). For 
the remaining herds, 1 isolate was used.
Phenotypic identification was based on colony mor-
phology on blood agar, CAMP (Christie, Atkins, Munch-
Peterson) reaction, and Lancefield grouping (15). Before 
use, isolates were stored at −80°C in brain–heart infusion 
broth (Oxoid, Basingstoke, UK) with 15% glycerol. After 
culture on blood agar, purity was checked and 1 colony 
was used to confirm species identity by PCR with prim-
ers STRA-AgI (5′-AAGGAAACCTGCCATTTG-3′) 
and 5′-STRA-AgII (TTAACCTAGTTTCTTTAAAAC-
TAGAA-3′). DNA extracts for molecular typing were pre-
pared from overnight cultures in brain–heart infusion broth 
by using a DNeasy Blood & Tissue Kit (QIAGEN, Man-
chester, UK). Species confirmation, multilocus sequence 
typing (MLST), and serotyping were conducted for all 
isolates. Pilus island (PI) typing and lactose typing were 
conducted for all isolates from humans and 1 isolate from a 
bovid per sequence type (ST) per herd.
MLST
MLST was performed by using standard primers and 
HiMLST or Sanger sequencing of purified PCR amplicons 
(16,17). Alleles and STs were assigned by using the S. aga-
lactiae database (http://pubmlst.org/sagalactiae/) (18). New 
alleles were submitted to the database curator for quality 
control and allocation of allele numbers and STs. Novel al-
lele combinations were also submitted for ST assignment.
Molecular Serotyping
For detection of molecular serotype (MS) II and MS IV, 
duplex PCR was used, and for detection of MS V, VI, VII, 
and VIII, multiplex PCR was used (19). PCR reactions for 
MS Ia, Ib, and III were run individually by using primers 
for MS Ia and Ib (19) and primers IIIcpsHS and IIIcpsHA 
for MS III (20). For all reactions, cycling conditions were 
94°C (5 min), followed by 40 cycles of 94°C (60 s), 55°C 
(60 s), and 72°C (60 s) with final extension at 72°C (5 min). 
Each isolate was submitted to all molecular serotyping re-
actions to identify potential cross-reactivity.
PI Typing
Multiplex PCR was used to screen for presence of sag647 
(PI-1), sag1406 (PI-2a), and san1517 (PI-2b); the house-
keeping gene adhP was used as amplification control (11). 
Isolates that were negative for PI-1 were tested for presence 
of an intact integration site. Detection of a 684-bp amplicon 
indicates presence of an intact site, and absence of the am-
plicon indicates occupation by an alternative, uncharacter-
ized genetic element. Isolates that were positive for PI-2a 
or PI-2b were further characterized by PI-specific PCR-
based restriction fragment length polymorphism analysis 
to detect allelic variation in the PI-2a adhesin gene (gbs59) 
and the PI-2b backbone protein (san1519) (11).
Lactose Typing
To detect lactose fermentation, we inoculated a single col-
ony into phenol red broth (neutralized soya peptone with 
beef extract; Oxoid), supplemented with phenol red and α 
lactose (L2643; Sigma-Aldrich, Gillingham, UK). Broth 
was incubated at 37°C without shaking and was checked 
for change from red to yellow at 24 h, 48 h, and 7 days 
after inoculation. PCR was used to screen for presence of 
an ≈2.5-kbp region of lacEFG, which is part of the Lac.2 
operon that encodes lactose fermentation (21).
Data Analysis
Comparisons of categorical variables were conducted in 
Statistix 10 (Analytical Software, Tallahassee, FL, USA) 
with use of the Fisher exact or Pearson χ2 test, as appro-
priate. Global eBURST analysis was performed by using 
PHYLOViZ (22); double-locus variants were included in 
eBURST groups.
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Results
MLST
All isolates were confirmed as S. agalactiae and 33 STs 
were identified. Isolates from humans belonged to 16 al-
lelic profiles, including 2 new profiles derived from iso-
lates from patients with invasive disease in Sweden. Both 
profiles were single-locus variants (SLVs) of known STs, 
with ST751 based on a new combination of known alleles, 
whereas the second profile was based on a new atr allele 
with an internal deletion (ST not assigned). ST1 was most 
common, followed by ST19 and ST12 (21, 14, and 10 iso-
lates, respectively). All STs were found in isolates from 
patients in at least 2 age groups and from 2 clinical sample 
types (online Technical Appendix Figure 3).
Among 108 isolates from cattle, 22 STs were identified, 
including 12 new STs (5 from Finland, 7 from Sweden). 
The proportion of new STs was higher among isolates from 
cattle than from humans (54.5% vs. 12.5%, respectively; 
Pearson χ2 = 4.7, df = 1, p = 0.03). A total of 3 new STs 
(ST632, ST633, ST726) were detected in multiple herds, 
whereas the remaining new STs (ST634–636, ST722–725, 
ST727, ST728) were each obtained from 1 herd. All were 
SLVs of known STs with 1 new allele. For 9 herds, >1 iso-
late was available and isolates within a herd belonged to 
a single ST, with 1 exception in which ST1 and its SLV 
ST635 were detected (online Technical Appendix Table 1). 
Both isolates from this herd were included in herd-level 
analysis and comparison between host species. In herd-lev-
el analysis of 74 isolates, ST1 was most common, followed 
by ST103 and ST196 (20, 10, and 8 herds, respectively; on-
line Technical Appendix Table 2). We found no significant 
association between ST and country of origin.
Of 33 STs in this study, 5 were detected in both host 
species (Figure 1). ST1 was the most common shared ST, 
followed by ST23, ST196, ST12, and ST8 (41, 12, 12, 11, 
and 7 isolates, respectively). More than half (84) of the 155 
isolates (54.2%) belonged to shared STs. Of 5 shared STs, 
4 were represented by >10 isolates compared with 2 of 28 
host-specific STs (p<0.001 by Fisher exact test). Using 
global eBURST, we identified 6 clusters, 2 of which were 
host specific (i.e., ST17 from humans and a cluster around 
ST103 from cattle). Both host-specific clusters included 
isolates from both countries (Figure 1).
Molecular Serotyping
Among isolates from humans, MS Ia, Ib, and II–VI were 
identified. Among isolates from cattle, 2 did not yield conclu-
sive molecular serotyping results. Among the remaining iso-
lates from cattle, MS Ia, Ib, II–V, and VII were identified. We 
found strong correlation between MS and ST (Table; online 
Technical Appendix Figure 4). For STs found in both host 
species, MS did not differ between isolates from humans or 
cattle, with the exception of ST23: isolates from humans be-
longed to MS Ia and those from cattle to MS Ia or III (Table).
PI Typing
We identified 5 PI profiles (Figure 2; online Technical Ap-
pendix Figure 5). Among PI-1–negative isolates, the inte-
gration site was intact in 14 of 19 isolates from humans 
Figure 1. Distribution of host 
species and countries across 
clusters of Streptococcus 
agalactiae sequence types (STs), 
with clusters including single- 
and double-locus variants. Each 
circle represents an ST, with 
size of the circle and its colored 
segments proportional to the 
number and origin of isolates, 
respectively. Red, human in 
Finland; yellow, human in 
Sweden; green, bovid in Finland; 
blue, bovid in Sweden. STs are 
indicated by numbers in the 
circles. Single- and double-locus 
variants are connected by  
black lines.
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and in 8 of 23 isolates from cattle (74% vs. 35%, χ2 = 6.31, 
df = 1, p = 0.01). Within host–ST combinations, results for 
PI-1 and occupation of the integration site were consis-
tent across isolates (online Technical Appendix Table 2). 
Across both host species, 1 PI-2a allele was identified in 
ST1, ST8, and ST196, respectively. ST12 included 2 PI-
2a alleles among isolates from humans (Figure 2). Within 
ST23, PI-2a alleles were MS specific. One combination 
was identified in both host species, and 1 was limited to 
cattle (Figure 2). PI-2b and PI-1 were present in all ST17 
isolates (from humans) and 1 ST724 isolate (from cattle), 
and PI-2b alone was present in isolates with cattle-specific 
STs (online Technical Appendix Figure 5). One PI-2b al-
lele was found in ST632, and a second allele was found 
across the entire bovine-specific eBURST cluster.
Lactose Typing
Of 81 isolates from humans and 73 isolates from cattle, 
lactose was fermented by 3 (3.7%) and 73 (100%), respec-
tively (χ2 = 142, df = 1, p<0.001). One isolate from cattle 
was nonviable and hence not tested. Of 81 isolates from 
humans, 2 (2.5%) were positive for lacEFG compared with 
69 (94.5%) of 73 isolates from cattle (χ2 = 131, df = 1, 
p<0.0001). Discrepancies between phenotype and geno-
type were confirmed by repeating culture, DNA extraction, 
and phenotypic and genotypic testing. Genotypic results 
that were atypical for the host species were observed only 
in STs that were found in both host species (i.e., in ST1, 
ST23, and ST196) (Figure 3).
Discussion
In contrast to results of previous studies (11,12), our re-
sults showed no clear distinction between subpopulations 
of S. agalactiae from humans or cattle according to MLST, 
molecular serotyping, or PI typing. With few exceptions 
(13,14), previous comparative studies were not based on 
contemporaneous, sympatric isolates across host species. 
Our study showed that ≈54% of isolates belonged to a 
population that affects both host species. The convenience 
sample used may not be fully representative of the distribu-
tion of STs across the human population in those countries, 
and invasive isolates were obtained only from Sweden, but 
no significant clustering by country or clinical manifesta-
tion was observed, suggesting that the observed ST distri-
bution is broadly indicative of the most common types.
The most prevalent shared ST was ST1. Its presence in 
cattle from several countries has been described, but high 
prevalence among cattle has been reported in Denmark 
only (11,12,23). Serotype V and PI type 1/2a were predom-
inant in ST1 from both host species, a finding that agrees 
with findings from previous studies (11,24). Surprisingly, 
ST196 was the second most common shared ST (equally 
with ST23), and all carried MS IV. Reports of ST196 and 
serotype IV used to be rare; only 1 of 158 isolates collected 
in Sweden over a 10-year period (1988–1997) belonged to 
ST196, but they are now recognized as emerging human 
pathogens (7,8,25). Furthermore, emergence of new STs 
with MS IV in humans, such as ST459, has been described 




Table. Streptococcus agalactiae isolates from humans and cattle, Finland and Sweden, 2010–2013* 
Molecular 
serotype 
No. isolates from humans/cattle 
 
No. isolates from humans only 
 
No. isolates from cattle only 
ST1 ST8 ST12 ST23 ST196 Other ST17 ST19 ST28 ST144 ST10 ST103 ST314 ST633 ST726 
Ia 1/0 – – 7/2 – 1/3  – – – 6  – 10 3 3 – 
Ib – 4/3 – – – 1/0  – – – –  1 – – – – 
II 1/0 – 10/1 – – 2/1  – 1 3 –  3 – – – – 
III – – – 0/2 – 1/4  4 13 – –  – – – – – 
IV – – – – 4/8 2/1  – – – –  – – – – 3 
V 18/19 – – – – 1/4  – – – –  – – – – – 
Other 1/1 – – 0/1 – –  – – – –  1 – – – – 
*ST, sequence type; –, no isolates. 
 
Figure 2. Distribution of pilus island profiles (A) and alleles within pilus island 2a (B) across Streptococcus agalactiae isolates from 
humans (dark bars) and bovids (light bars). Letter and number combinations in B show sequence type (ST), molecular serotype (Roman 
numeral), and allele for pilus island 2a (capital letter).
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in cattle, ST723, in multiple dairy herds in Sweden. The 
relatively common occurrence of ST196 and its SLVs in 
cattle in the Nordic countries (this study; 26) suggests that 
cattle may serve as a reservoir for MS IV strains, although 
our study does not provide evidence for the direction or 
likelihood of potential transmission between host species.
ST23 affects many host species (12,27). In humans, it 
is more commonly associated with carriage than with infec-
tion (16,24), although all ST23 in our study originated from 
infections. Most ST23 from humans have serotype Ia, and 
it has been suggested that serotype III originated in cattle, 
but the association between host and serotype is not absolute 
(16,23,24). In our collection, ST23 from humans was associ-
ated with MS Ia, whereas isolates from cattle were associat-
ed with MS Ia or MS III. PI profiles for ST23 matched those 
described for other countries (11). ST8, which was found 
across countries and species, and ST12, which was limited to 
Finland but isolated from both host species, have also been 
associated with carriage and invasive disease in humans, al-
beit at lower frequency than ST1 or ST23 (16,24,25). ST8 
from both hosts had MS 1b and carried PI-1/2a, as previous-
ly described for isolates from humans (11,28). ST12 isolates 
from our study were associated with MS II, regardless of host 
species, and mostly carried PI-1/2a. This pattern matches re-
ports of isolates from humans, although ST12 from humans 
may occasionally have serotype Ib (11,28).
The shared pathogen population may result from 
transmission between host species or shared exposure to 
an external source. Potential routes of transmission from 
cattle to humans include direct contact, exposure to cattle 
feces, and consumption of cows’ milk. Potential routes of 
transmission from humans to cattle include direct contact 
and indirect exposure to excreta from humans. In one pro-
spective study, increased frequency of cattle exposure was 
associated with human colonization with S. agalactiae, al-
though fecal colonization was detected in 1 cow only (14). 
The prevalence of fecal colonization on individual farms 
can be high (26), but gastrointestinal carriage is much more 
widespread among humans (16,29), which argues against 
exposure to cattle feces as a dominant reservoir for hu-
man colonization. Case reports and phenotyping of isolates 
show that raw milk consumption may lead to colonization 
of the human throat (30). This route may be of public health 
relevance in countries where milk is frequently consumed 
raw (e.g., Colombia) but not in countries where milk is rou-
tinely pasteurized (e.g., Europe and most of North Amer-
ica). In studies conducted in the United States, no signifi-
cant association has been detected between consumption of 
milk and colonization of humans (29,31).
Several lines of evidence suggest that humans may 
be a source of infection for cattle. Experimental intrama-
mmary challenge of cattle with isolates of S. agalactiae 
from humans resulted in mastitis, although the duration of 
intramammary infection and hence the window of opportu-
nity for transmission was less than that for infection with 
isolates from cattle (32). Similar observations have been 
made for naturally occurring bovine mastitis, whereby inci-
dental cases in dairy herds were caused by strains that were 
otherwise predominantly found in humans (33). Epidemio-
logic studies also support the role of S. agalactiae sources 
other than cattle because introduction of the pathogen into 
dairy herds can often not be attributed to purchase of cattle, 
implying that alternative sources must exist (9). Some on-
farm studies suggest that treatment of human oropharyn-
geal S. agalactiae carriers is a crucial step for eliminating 
S. agalactiae from dairy herds (34). Considering the fre-
quent colonization of the human throat, gut, and urogenital 
tract with the shared STs observed in this study and the 
direct contact between human hands and the bovine mam-
mary gland during milking, with or without use of gloves, 
a plausible mechanism for human-to-cattle transmission 
exists. The main difficulty in determining directionality of 
transmission between host species is establishing the order 
of events (i.e., which host species was positive first). Fur-
thermore, efforts to detect alternative, potentially shared 
sources of S. agalactiae are limited by the preconceived but 
mistaken notion that S. agalactiae is an obligate intramam-
mary pathogen in dairy cattle. Potentially shared sources 
include wastewater and surface water, including effluent 
from sewage treatment plants (27,35,36). Potential routes 
of within- and between-host species transmission, includ-
ing horizontal and vertical transmission among humans 
(12,31,37) and contagious transmission among cattle via 
milking machines (12,26), are summarized in online Tech-
nical Appendix Figure 6.
Alternatively, the co-occurrence of STs in both host spe-
cies may not be the result of ongoing interspecies transmis-
sion but rather that of incidental spillover, with subsequent 
adaptation and dissemination within the new host, leading to 
Figure 3. Distribution of lacEFG PCR–positive (pos) and  
–negative (neg) human (H) and bovine (B) Streptococcus 
agalactiae isolates across sequence types (ST). STs found in both 
host species are shown individually, whereas STs that were found 
in a single species are grouped by species.
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parallel circulation of populations that have the same ST but 
encode host-specific adaptations elsewhere in the genome. 
This chain of events has been described for Staphylococcus 
aureus (38). Among S. agalactiae isolates from cattle, >90% 
are lactose fermenters, whereas the reverse is true among 
isolates from humans, providing an example of a host adap-
tation mechanism (10,23). The genes targeted by our PCR, 
lacEFG, form part of the Lac.2 operon, which is located on 
an integrative conjugative element and forms part of the 
S. agalactiae mobilome (10). Regulation of the S. agalac-
tiae mobilome is a relatively new area of study (39); little 
is known about its contribution to host adaptation or inter-
species transmission. Atypical combinations (i.e., lacEFG-
positive isolates from humans and lacEFG-negative isolates 
from cattle) belonged to STs that are shared across host spe-
cies, potentially indicating recent transmission events.
In our study, 2 STs occurred frequently but in only 1 
host species. ST19 was commonly detected in humans but 
not in cattle. ST19 is generally rare in cattle, although its 
association with humans is not absolute (11,12). Converse-
ly, ST103 was commonly found in cattle in our study and in 
Denmark, Norway, and China (12,26,40) but not in isolates 
from humans in our study or those mentioned in any of the 
references cited. ST103 and its SLVs were invariably as-
sociated with serotype Ia (40) and PI-2b (online Technical 
Appendix Figure 5). We detected 4 new STs in the eBURST 
cluster around ST103, indicating ongoing evolution of this 
cattle-specific subpopulation. Those STs, and all other new 
STs detected in this study, were SLVs of known STs. The 
fact that all new STs were limited to 1 country and that they 
were SLVs of existing STs indicates that we still observe 
local microevolution but that we are starting to exhaust the 
variability in the S. agalactiae population.
In summary, according to MLST, molecular serotyp-
ing, and PI typing of contemporaneous S. agalactiae iso-
lates from humans and cattle in Finland and Sweden, we 
identified 3 subpopulations: 1 from humans, 1 from cattle, 
and 1 from both hosts. The latter subpopulation accounted 
for more than half of the isolates, implying that the host 
species barrier separating S. agalactiae from both species 
may be more porous than previously thought. For STs com-
monly carried by humans (e.g., ST1 and ST23), the direc-
tion of transmission, if any, may be from humans to cattle. 
ST196/MS IV was relatively common among cattle, which 
may potentially constitute a reservoir of this recently rec-
ognized emerging pathogen of humans. The only charac-
teristic that differentiated most isolates from the 2 species 
in this study was the ability to ferment lactose, which is 
encoded in the mobilome. Considering the new evidence 
for potential interspecies transmission of S. agalactiae, its 
emergence in adult humans and its reemergence in cattle, 
further studies into the mechanisms and frequency of trans-
mission and host adaptation seem warranted.
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